Phenergan and Buspirone hcl drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Phenergan (promethazine hydrochloride) and Buspirone hcl (buspirone hydrochloride). Common drug interactions include haematocrit decreased among females and drug exposure during pregnancy among males.
The phase IV clinical study analyzes what interactions people have when they take Phenergan and Buspirone hcl. It is created by eHealthMe based on reports of 74 people who take the same drugs from the FDA, and is updated regularly.
What is Phenergan?
Phenergan has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 25,312 Phenergan users. Check the latest studies of Phenergan.
What is Buspirone hcl?
Buspirone hcl has active ingredients of buspirone hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 9,821 Buspirone hcl users. Check the latest studies of Buspirone hcl.
74 people who take Phenergan and Buspirone hcl together, and have interactions are studied.

What are the common drug interactions of Phenergan and Buspirone Hcl, by gender? *:
female:
- Haematocrit decreased
- Haemoglobin decreased
- Hospitalisation
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Influenza like illness
- Infusion site infection
- Infusion site pain
- Infusion site swelling
- Headache (pain in head)
- Abdominal pain
male:
- Drug exposure during pregnancy
- Mitral valve stenosis (narrowing of mitral valve)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
- Blood pressure decreased
- Emergency care
- Erectile dysfunction
- Maternal exposure before pregnancy (use of substance before pregnancy)
- Maternal exposure during pregnancy (use of substance during pregnancy)
- Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
What are the common drug interactions of Phenergan and Buspirone Hcl, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Emergency care
- Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
- Suicidal ideation
- Therapeutic response unexpected
20-29:
- Abdominal pain
- Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
- Cholecystitis chronic (long lasting infection of gallbladder)
- Diarrhoea
- Retching (strong involuntary effort to vomit)
- Migraine (headache)
- Parasomnia (sleep disorders that involve abnormal and unnatural movements, behaviours, emotions, perceptions)
- Pyrexia (fever)
- Sleep terror (felling of terror in sleep)
- Tremor (trembling or shaking movements in one or more parts of your body)
30-39:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Back pain
- Cholecystitis chronic (long lasting infection of gallbladder)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
- Dyspepsia (indigestion)
- Emotional distress
- Fear
- Hospitalisation
40-49:
- Asthma
- Cardiac disorder
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Headache (pain in head)
- Hypersensitivity
- Infusion related reaction
- Lower limb fracture
- Lower respiratory tract infection
- Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
- Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
50-59:
- Constipation
- Decreased appetite
- Diarrhoea
- Fall
- Gastrointestinal infection (infection of stomach and intestine)
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Hypertension (high blood pressure)
- Infusion site erythema (reddening of the skin at infusion site)
- Infusion site rash
- Initial insomnia (feeling of inadequate or poor-quality sleep)
60+:
- Fall
- Headache (pain in head)
- Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Pneumonia
- Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Ventricular extrasystoles (premature cardiac contraction)
- Vulvovaginal candidiasis (vulvovaginal infection by fungi)
- Arthralgia (joint pain)
What are the existing conditions these people have? *
- Depression: 15 people, 20.27%
- Pain: 13 people, 17.57%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 13.51%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 12.16%
- Asthma: 7 people, 9.46%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 7 people, 9.46%
- Nausea And Vomiting: 6 people, 8.11%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 8.11%
- Dissociative Disorder: 5 people, 6.76%
- Intervertebral Disc Degeneration (spinal disc degeneration): 5 people, 6.76%
* Approximation only. Some reports may have incomplete information.
Do you take Phenergan and Buspirone hcl?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Phenergan (25,312 reports)
- Buspirone hcl (9,821 reports)
Browse all drug interactions of Phenergan and Buspirone hcl:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Phenergan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Buspirone hcl:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Phenergan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Buspirone hcl and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on promethazine hydrochloride and buspirone hydrochloride (the active ingredients of Phenergan and Buspirone hcl, respectively), and Phenergan and Buspirone hcl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Clonazepam cause Eating Disorder? - 3 seconds ago
- Drug interactions of Ozempic and Hctz - 4 seconds ago
- Could Myrbetriq cause Ocular Hyperaemia? - 10 seconds ago
- Could Finasteride cause Oesophagitis Aggravated? - 21 seconds ago
- Drug interactions of Percocet and Mupirocin - 25 seconds ago
- Drug interactions of Cisplatin and Claritin - 25 seconds ago
- Riboflavin vs. Darvocet-N 100, side effect and effectiveness comparison - 27 seconds ago
- Could Omeprazole cause Electrocardiogram T Wave Inversion? - 32 seconds ago
- Drug interactions of Ultram and Anaprox - 36 seconds ago
- Could Atenolol cause Hypertrophic Cardiomyopathy? - 37 seconds ago